Sign Up! | Tags | Domains | Statistics | Options | Advanced Search
|
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
 |
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Saysxconomy.com » Xconomy Boston - Nov 13, 2008 Biotech, RNA Interference, Arthritis Luke Timmerman wrote: Everywhere he goes in biotechnology circles, RXi Pharmaceuticals’ CEO Tod Woolf hears the same criticism of RNA interference drugs. What can be done to … Also tagged: asthma, biotech, boston, type 2 diabetes, arthritis, amgen, atherosclerosis, etanercept, crohn s disease, remicade, life sciences, psoriasis, abbott laboratories, enbrel, rna interference, boston blog main, national blog main, alnylam pharmaceuticals, craig mello, rxi pharmaceuticals, tod woolf, johnson and 38 johnson, infliximab, michael czech, gary ostroff, adalimumab |
 |
Personalized Treatments for Cancer: Ensemble Moves Ahead with Roche on New Breed of Testxconomy.com » Xconomy Boston - Nov 13, 2008 Biotech, cancer, Personalized Medicine Luke Timmerman wrote: Some of the world’s biggest selling cancer drugs today work for only a small fraction of patients, and researchers have struggled to say for sure why that … Also tagged: cancer, biotech, boston, herceptin, amgen, boston university, genentech, osi pharmaceuticals, cetuximab, erbitux, harvard university, roche, etanercept, personalized medicine, life sciences, tarceva, david liu, trastuzumab, abbott laboratories, erlotinib, enbrel, imclone systems, mike taylor, tnf, boston blog main, flagship ventures, national blog main, arch venture partners, cmea ventures, johnson and 38 johnson, infliximab, harris and 38 harris group, adalimumab, laurence reid, david livingston, ensemble discovery |
|
Personalized Treatments for Cancer: Ensemble Moves Ahead with Roche on New Breed of Testxconomy.com » Xconomy Life Sciences Feed - Nov 12, 2008 Biotech, cancer, Personalized Medicine Luke Timmerman wrote: Some of the world’s biggest selling cancer drugs today work for only a small fraction of patients, and researchers have struggled to say for sure why that … Also tagged: cancer, biotech, boston, herceptin, amgen, boston university, genentech, osi pharmaceuticals, cetuximab, erbitux, harvard university, roche, etanercept, personalized medicine, life sciences, tarceva, david liu, trastuzumab, abbott laboratories, erlotinib, enbrel, imclone systems, mike taylor, tnf, boston blog main, flagship ventures, national blog main, arch venture partners, cmea ventures, johnson and 38 johnson, infliximab, harris and 38 harris group, adalimumab, laurence reid, david livingston, ensemble discovery |
 |
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy - Nov 8, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, vioxx, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, illumina, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
|
Illumina Shows its Stuff to Wall Street, Stock Still Slidesxconomy.com » Xconomy Life Sciences Feed - Nov 7, 2008 Biotech, Genetics, Instruments Luke Timmerman wrote: San Diego’s Illumina has a pretty amazing story to tell about exponential growth. The maker of genetic analysis tools has beaten or matched Wall Street earnings … Also tagged: google, biotech, genetics, applied biosystems, multiple sclerosis, fda, san diego, amgen, merck, type 1 diabetes, harvard, instruments, sergey brin, roche, vioxx, etanercept, anne wojcicki, inflammatory bowel disease, life sciences, illumina, 23andme, rheumatoid arthritis, abbott laboratories, enbrel, national blog main, george church, helicos biosciences, cowen and 38 co, san diego blog main, jay flatley, adalimumab, christian henry, tristan orpan, doug schenkel, peter gregersen |
 |
Earnings highlights: Google, Intel, Coca-Cola, Pfizer, eBay, AMD and othersbloggingstocks.com » BloggingStocks - Oct 27, 2008 Filed under: Earnings reports, Google (GOOG), eBay (EBAY), Pfizer (PFE), Coca-Cola (KO), Intel (INTC), Nokia Corp. (NOK), Advanced Micro Dev (AMD), Abbott Laboratories (ABT), Xerox Corp (XRX), Reliance Steel and … Also tagged: google, ebay, abt, pfe, goog, amd, intc, jbht, intel, abbott, nokia, nok, ge, gs, ko, earnings, featured, ethanol, coca cola, coke, general electric, pfizer, xerox, jim cramer, www, isrg, rs, xrx, goldman sachs, fuel prices, intuitive surgical, csx, earnings reports, jb hunt, abbott labs, reliance steel, wolverine world wide, royal phillips |
 |
Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadlinexconomy.com » Xconomy - Oct 10, 2008 Biotech, Fibromyalgia, Cypress Bioscience Luke Timmerman wrote: Cypress Bioscience is one of those biotech companies that has limped along for more than 20 years, losing loads of money. In the lovely language of chief … Also tagged: biotech, fda, san diego, pfizer, amgen, eli lilly, cymbalta, lyrica, fibromyalgia, life sciences, cypress bioscience, abbott laboratories, forest laboratories, enbrel, national blog main, san diego blog main, milnacipran, sabrina johnson |
|
Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadlinexconomy.com » Xconomy Life Sciences Feed - Oct 9, 2008 Biotech, Fibromyalgia, Cypress Bioscience Luke Timmerman wrote: Cypress Bioscience is one of those biotech companies that has limped along for more than 20 years, losing loads of money. In the lovely language of chief … Also tagged: biotech, fda, san diego, pfizer, amgen, eli lilly, cymbalta, lyrica, fibromyalgia, life sciences, cypress bioscience, abbott laboratories, forest laboratories, enbrel, national blog main, san diego blog main, milnacipran, sabrina johnson |
telegraph.co.uk » Telegraph UK News - Sep 30, 2008
A leading fertility doctor allegedly failed to properly care for a patient who arrived at his clinic vomiting and was later admitted to intensive care.
Also tagged: gmc, fertility treatment, infertility treatment, general medical council, mohamed taranissi, argc, assisted reproduction and gynaecology centre
injuryboard.com » InjuryBoard Local Blogs - Sep 11, 2008
Last week, the FDA ordered that warnings for several popular arthritis drugs be strengthened once again due to concerns about increased risks of life-threatening fungal infections. The new warnings would apply to …
Also tagged: fungal infection, remicade, enbrel, cimzia, fda and prescription drugs